February 6, 2019adminNewsmakersComments Off on FSD Pharma (OTC: FSDDF) Announces Signing of LOI with Solarvest to Develop and Test Pharma-Grade Cannabinoids out of Algae
PHARMA GRADE PROCESS COULD REDUCE THE PRODUCTION TIME FOR TARGETED CANNABINOID MOLECULE(S) FSD Pharma Inc. (“FSD Pharma”)(OTC: FSDDF) and Solarvest BioEnergy Inc. (SVS) (“Solarvest”) ()Parties”), a technology company which has developed an algal-based flexible production platform […]
January 4, 2019adminNewsmakersComments Off on Elixinol (OTC: ELLXF) Welcomes Hemp Industry Advocate Joy Beckerman As Regulatory Officer & Industry Liaison
Beckerman will represent Elixinol’s position in hemp industry’s dynamic U.S. regulatory and advocacy environment DENVER , Jan 03, 2019 — Elixinol, a wholly owned subsidiary of Elixinol Global (EXL) (asx:EXL) announces Joy Beckerman’s appointment to Elixinol’s […]
Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.